Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

Recruiting now · Not applicable

Conditions studied: Colorectal Cancer

In brief

This study aims to explore the safety and efficacy of intermittent hypoxia intervention on patients with colorectal cancer.

Key facts

Study ID

NCT06584318

Run by

Capital Medical University

People needed

20

Starts

2024-03-01

Expected to finish

2026-04-30

Last updated by the study team

2025-05-28

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with colorectal cancer between ages of 18 and 65 years.
• Colorectal cancer stage Ⅰ,Ⅱ.
• Subjects or their legally authorized representative can provide informed consent.

You may not qualify if…

• History of cardiovascular, cerebrovascular, dermatological, and hematological diseases.
• History of pulmonary, hepatic, kidney, dermatologic and hematologic diseases.
• History of pregnancy, hypertension, diabetes mellitus, obesity, sleep apnea and neurological disorders.
• History of substance abuse.
• Participating in other drug or medical device studies.
• History of organ transplantation, including allogeneic stem cell and immune cell transplantation.
• Recent severe infection within 4 weeks.
• Received cancer treatment, including chemotherapy and radiotherapy, within 4 weeks.
• Underwent major surgery within 28 days.

Where it is running

• Xuanwu Hospital, Capital Medical University — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.